Hilltop Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.86M | Buy |
4,177
+542
| +15% | +$241K | 0.12% | 200 |
|
2025
Q1 | $1.76M | Buy |
3,635
+90
| +3% | +$43.6K | 0.11% | 197 |
|
2024
Q4 | $1.43M | Buy |
3,545
+402
| +13% | +$162K | 0.09% | 240 |
|
2024
Q3 | $1.46M | Buy |
3,143
+2,459
| +360% | +$1.14M | 0.09% | 230 |
|
2024
Q2 | $321K | Hold |
684
| – | – | 0.04% | 458 |
|
2024
Q1 | $286K | Buy |
684
+2
| +0.3% | +$836 | 0.03% | 512 |
|
2023
Q4 | $277K | Sell |
682
-10
| -1% | -$4.07K | 0.03% | 485 |
|
2023
Q3 | $241K | Sell |
692
-11
| -2% | -$3.83K | 0.03% | 498 |
|
2023
Q2 | $247K | Sell |
703
-7
| -1% | -$2.46K | 0.03% | 477 |
|
2023
Q1 | $224K | Sell |
710
-2
| -0.3% | -$630 | 0.03% | 474 |
|
2022
Q4 | $206K | Hold |
712
| – | – | 0.03% | 484 |
|
2022
Q3 | $206K | Buy |
+712
| New | +$206K | 0.03% | 467 |
|
2021
Q2 | – | Sell |
-1,509
| Closed | -$324K | – | 591 |
|
2021
Q1 | $324K | Buy |
+1,509
| New | +$324K | 0.04% | 386 |
|
2020
Q3 | – | Sell |
-757
| Closed | -$220K | – | 452 |
|
2020
Q2 | $220K | Buy |
+757
| New | +$220K | 0.04% | 351 |
|
2018
Q4 | – | Sell |
-1,534
| Closed | -$296K | – | 420 |
|
2018
Q3 | $296K | Buy |
+1,534
| New | +$296K | 0.06% | 317 |
|